Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
            
  Top » Catalog » Journals » Functional Neurology, Rehabilitation, and Ergonomics » Volume 1 Issue 3 Articles » My Account  |  Cart Contents  |  Checkout   
Quick Find
  
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Theory of Literature
$270.00
Shopping Cart more
0 items
Information
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Bestsellers
01.Commentary on Hinz et al. (2011) on the Non-Validity and Clinical Relevance of Neurotransmitter Testing (pp. 515-519)
Notifications more
NotificationsNotify me of updates to Commentary on Hinz et al. (2011) on the Non-Validity and Clinical Relevance of Neurotransmitter Testing (pp. 515-519)
Tell A Friend
 
Tell someone you know about this product.
Commentary on Hinz et al. (2011) on the Non-Validity and Clinical Relevance of Neurotransmitter Testing (pp. 515-519) $40.00
Authors:  Datis Kharrazian
Abstract:
Hinz et al. [1] comments that if the author [2] had included papers published by Hinz et al. in regards to renal physiology, the author may have developed a different conclusion regarding the non-validity of neurotransmitter testing. They comment that the authorís understanding of renal physiology is not discussed and is superficial [1]. Instead, this assumption represents a narrow understanding of clinical neurophysiology. The author is familiar with the publications of Hinz et al. and did not include them in the original paper because the conclusions of these papers are speculative and theoretical and offer no science in validating any form of neurotransmitter testing [1-11]. The referenced papers by Hinz et al. limit their focus to renal physiology and precursor amino acid loading. They do not discuss physiological properties of neurotransmitter activity before and after monoamine renal physiology. These mechanisms include modulation of rate-limiting enzyme for synthesis, neurotransmitter transport outside of the kidneys, neurotransmitter homotrophic and heterotrophic modulation, receptor site sensitivity, and post-translational receptor expressions, to name a few. Assessing neurotransmitter clinical validity exclusively by monoamine renal physiology demonstrates a lack of understanding of neurotransmitter dynamics. There is no evidence from any of the papers published or referenced by Hinz et al. that urinary neurotransmitter testing of any type correlates with neurotransmitter activity of the central nervous system. 


Available Options:
Version:
Customers who bought this product also purchased

Nutritional and Dietary Considerations for Basal Ganglia Disorders (pp. 227-242)
Special Focus Titles
01.Violent Communication and Bullying in Early Childhood Education
02.Cultural Considerations in Intervention with Women and Children Exposed to Intimate Partner Violence
03.Chronic Disease and Disability: The Pediatric Lung
04.Fruit and Vegetable Consumption and Health: New Research
05.Fire and the Sword: Understanding the Impact and Challenge of Organized Islamism. Volume 2

Nova Science Publishers
© Copyright 2004 - 2021

Commentary on Hinz et al. (2011) on the Non-Validity and Clinical Relevance of Neurotransmitter Testing (pp. 515-519)